MAFLD and impaired bone formation in children: association with reduced serum LCAT
Purpose To evaluate bone metabolism indicators and serum lecithin–cholesterol acyltransferase (LCAT) levels in children with metabolic dysfunction-associated fatty liver disease (MAFLD), and to explore their interrelationship. Patients and Methods This study enrolled 127 children aged 6–14 years, classified into contro...